Nadia Jahroudi

Author PubWeight™ 9.04^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases.	J Biol Chem	2003	1.16
2	CLIC5A, a component of the ezrin-podocalyxin complex in glomeruli, is a determinant of podocyte integrity.	Am J Physiol Renal Physiol	2010	0.99
3	Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling.	Stem Cells Dev	2009	0.99
4	The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter.	Blood	2002	0.95
5	Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice.	J Biol Chem	2007	0.91
6	Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells.	Arterioscler Thromb Vasc Biol	2013	0.86
7	Valproic acid exerts differential effects on CXCR4 expression in leukemic cells.	Leuk Res	2009	0.82
8	Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ.	J Cell Sci	2013	0.81
9	Histone H1-like protein participates in endothelial cell-specific activation of the von Willebrand factor promoter.	Blood	2004	0.81
10	Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.	Arterioscler Thromb Vasc Biol	2010	0.78